By The Numbers
- CNBC VIDEO: Warren Buffett & Bill Gates 'Walk & Talk' at Columbia University
- Time to Buy Treasurys?
- Lightning Round: Las Vegas Sands, ADC Telecom, Satyam Computer and More
- Lightning Round OT: Knight Capital, Ebix and More
- Is Lear, Back From Bankruptcy, a Buy?
- Sanofi-Aventis Falling Off a Patent Cliff?
- Cramer: Your Thanksgiving Week Game Plan
- Your First Move For Monday November 23rd
- Burned By JPMorgan, Whirlpool & More
- The Latest Picks That Paid - Friday November 20th
RSS FEED
Director of Market Data & Content Services
This weekend, the US House of Representatives passed its version of health care reform and now awaits a version from the Senate. The debate has been heating up since earlier this summer when President Obama was pushing for legislation before the summer recess.
Since the start of June, the S&P 500 Health Care sector is up over 13%. The sector is also up just under 10% for the year, and has been lagging the overall S&P [.SPX
Loading...
()
]as investors have been waiting to see how the reform story unfolds. Nonetheless, there have been some health care stocks that have surged over the past 6 months. Top amongst them is the health care technology company, IMS Health [RX
Loading...
()
], up 73% since June 1 and up 38% on the year. Biotechs seem to have fared worst since the summer, taking half of the bottom 8 spots. Biotechs are also the worst performing healthcare subindustry on the year.
Here are the biggest S&P Health Care gainers and losers over while the debate has waged on.
Top 10 S&P 500 Health Care Stocks Since June 1
![]() |
Bottom 10 S&P 500 Health Care Stocks Since June 1
![]() |
Comments? Send them to
- Technology can make or break a fortune in the world of alternative energy.
- Warren Buffett and Bill Gates discuss the economy and other subjects with CNBC's Becky Quick.
- Many people are facing the holidays with substantially smaller incomes. Here’s how some are adapting.
- Jim Cramer is a proponent of stocks that pay healthy dividends, and here are his top five dividend plays.
- The homebuyer's tax credit jacked sales for a while, but 2010 is looking weak. Now what?
- CNBC’s technology reporter Jim Goldman guides you through the best gadgets to buy this holiday season.













